FDA Recalls Nearly 90,000 Bottles of Children’s Ibuprofen Due to ‘Foreign Substance’
TODAY.com • • business
Key Points:
- The U.S. FDA has announced a recall of nearly 90,000 bottles of Children’s Ibuprofen Oral Suspension due to the presence of a foreign substance.
- The affected product is Strides Pharma’s 100 mg Children’s Ibuprofen, sold in 4 FL OZ bottles, manufactured for Taro Pharmaceuticals USA, Inc., with lot numbers 7261973A and 7261974A, expiring on January 31, 2027.
- The recall was voluntary, initiated by Strides Pharma after complaints reported a gel-like mass and black particles in the medicine; the FDA classified it as a Class II recall, indicating possible temporary or reversible health effects.
- Consumers are advised to immediately stop using the recalled product
